
Sign up to save your podcasts
Or


What does it really take to lead a biotech company when the science is complex, the stakes are high and the answers aren’t always obvious?
In this episode of She Leads Biotech, I’m joined by Iris Grossman, PhD, CEO of Zelig Therapeutics, for a candid conversation about the realities of biotech leadership and her journey from scientist to CEO.
In When Leadership Gets Real: Ego, Accountability & the Decisions That Shape Biotech Companies, we talk about what happens when leadership moves beyond the title and you become the person ultimately accountable for the decisions.
We explore why great leaders surround themselves with people who will challenge them, how founders and leadership teams need to evolve as companies grow, why strategy starts with knowing your values, and what Iris has learned about hiring beyond technical capability.
Iris also talks openly about making decisions without perfect information, handling difficult performance conversations, keeping ego out of leadership — and why patient impact remains her North Star.
Chapters
00:00 Introduction
03:17 A Patient-Centric North Star
05:46 The Scientist Inside the CEO
07:04 Turning Science into Patient Impact
10:14 The Reality of CEO Accountability
13:30 When Founders and Companies Need to Evolve
14:39 Why Independent Boards Matter
15:43 Strategy Starts with Values
17:17 Why Zelig Became a Call to Action
20:01 Making Decisions Through Uncertainty
23:28 Why Personality Matters in Hiring
26:24 The Difficult People Decisions Leaders Must Make
30:09 Why Biotech Is Ultimately About People
🎧 Follow She Leads Biotech for more conversations with the people building, leading and shaping biotech.
#SheLeadsBiotech #BiotechLeadership #Biotech #LifeSciences #WomenInBiotech #Leadership
What happens when the career plan you thought you had suddenly changes?
In this episode of She Leads Biotech, I’m joined once again by Priya Baraniak, PhD, Chief Commercial & Development Officer at Pluristyx, who returns to the podcast after first joining me back in Season 1.
In When the Plan Changes: Resilience, Reinvention & Finding Your Way in Biotech, we talk candidly about unexpected career change, resilience and what happens when you have to let go of the plan and find a different way forward.
Priya shares what she learned following a professional setback, why personal branding and authentic relationships became so important, and how her own career has evolved from scientist to commercial biotech leader.
We also explore the realities of biotech fundraising, what investors look for in leadership teams, the potential of iPSC technology and cell and gene therapy — and why, despite the challenges facing our industry, Priya remains incredibly excited about what the science can achieve for patients.
Above all, it’s a conversation about becoming more comfortable with uncertainty, focusing on what you can control and continuing to do the next right thing.
Chapters
01:23 When Everything Changes
05:25 Losing a Role: The First 72 Hours
10:05 Personal Branding & Getting Comfortable Being Visible
14:50 The Promise of iPSCs
18:00 From Scientist to Commercial Leader
21:31 What Fundraising Really Looks Like Today
23:29 Changing the Conversation About Inclusion
28:28 Why Cell & Gene Therapy Still Excites Her
31:28 What 13-Year-Old Priya Would Think Today
35:27 Just Keep Doing the Next Right Thing
37:02 Tough Times Didn't Break Us, They Made Us
🎧 Follow She Leads Biotech for more conversations with the people building, leading and shaping biotech.
#SheLeadsBiotech #Biotech #BiotechLeadership #CellAndGeneTherapy #WomenInBiotech #LifeSciences #BiotechCareers
Reimagining Rare Disease Drug Development with Nerissa Kreher
In this episode of She Leads Biotech, I’m joined by Nerissa Kreher, Chief Medical Officer of Alltrna, for a conversation about rare disease innovation, precision medicine, and the future of drug development.
With more than 20 years of experience in rare diseases, Nerissa shares her journey from pediatric endocrinologist to biotech executive and explains how Alltrna is taking a novel approach to treating genetic diseases through mutation-defined therapies.
A fascinating discussion about science, innovation, leadership, and hope for families living with rare diseases.
Chapters
00:00 Introduction
02:00 From Medicine to Biotech
05:00 Falling in Love with Rare Disease Research
08:00 Understanding Rare Disease Communities
12:00 The Challenge of Clinical Trials in Rare Diseases
16:00 Mutation-Defined Therapies Explained
21:00 How Alltrna Is Rethinking Drug Development
26:00 Regulatory & Clinical Development Challenges
31:00 Public vs Private Company Leadership
35:00 What Makes a Great Biotech Executive
39:00 Leadership, Mentorship & Authenticity
43:00 The Role of Patients in Drug Development
47:00 The Future of Rare Disease Innovation
51:00 Bringing Hope to Patients & Families
#SheLeadsBiotech #RareDisease #PrecisionMedicine #GeneTherapy #BiotechLeadership #WomenInBiotech #CNAUSAExecutiveSearch
Leading with Purpose in Rare Disease with Sarah DiSalvatore
In this episode of She Leads Biotech, I’m joined by Sarah DiSalvatore, Fractional SVP of Clinical Operations & Biotech Executive, for a conversation about leadership, rare disease, and the realities of bringing innovative therapies to patients.
Sarah shares her journey from bench research to executive leadership, why quality and compliance are fundamental to successful clinical development, and how fractional leadership is helping early-stage biotech companies build smarter and more efficiently.
We also discuss the deeply personal experience of becoming a rare disease parent, and how that has transformed the way Sarah approaches patient advocacy, programme development, and the importance of building centres of excellence for underserved communities.
A thoughtful conversation about resilience, strategy, and keeping patients at the centre of every decision.
Chapters
00:00 Introduction
02:00 A Childhood Dream of Medicine
06:00 From Bench Research to Clinical Operations
11:00 Why Quality and Compliance Matter
16:00 Growing into Leadership
20:00 The Rise of Fractional Executives
25:00 Becoming a Rare Disease Parent
30:00 How Personal Experience Changed Clinical Development
34:00 Building Centres of Excellence for Rare Diseases
38:00 The Future of Clinical Operations
42:00 Advice for Parents, Caregivers & Leaders
#SheLeadsBiotech #RareDisease #ClinicalOperations #BiotechLeadership #GeneTherapy #WomenInBiotech #CNAUSAExecutiveSearch
Beyond Burnout: Rethinking Leadership and Identity with Melody Keel
In this episode of She Leads Biotech, I’m joined by Melody Keel, CEO of The Research Associate Group, for a candid conversation about clinical operations, leadership, burnout, and building a life beyond your job title.
With more than 20 years of experience in clinical operations, Melody shares what she’s learned about leading teams, navigating high-pressure environments, and why empathy is one of the most powerful tools a leader can have.
We also discuss the changing biotech job market, the importance of personal branding, and why your career should never become your entire identity.
Whether you work in clinical operations or any area of life sciences, this episode is packed with practical insights and honest reflections.
Chapters
00:00 Introduction
02:10 Falling into Clinical Operations
05:00 Why Great Leaders Put People First
09:30 The Reality of Burnout in ClinOps
14:00 Sponsor vs CRO Life
17:20 A Personal Wake-Up Call
20:00 Building a Life Beyond Work
23:00 The Future of Careers in Biotech
27:00 Why Your Personal Brand Matters
30:00 Supporting Women Through Career Change
33:00 Finding Your Purpose Beyond Your Job
#SheLeadsBiotech #ClinicalOperations #Leadership #WomenInBiotech #CareerGrowth #LifeSciences #CNAUSAExecutiveSearch
Building Your Own Table with Jennifer Daily
In this episode of She Leads Biotech, I’m joined by Jennifer Daily, neuroscientist, biotech executive, and founder, for a conversation about leadership, drug development, and the journey from employee to entrepreneur.
Jennifer shares how working across clinical development, regulatory affairs, manufacturing, and preclinical research gave her a unique perspective on what it really takes to move therapies from concept to patient.
We also discuss the realities of gene therapy, why execution is often more important than great science alone, the power of building a strong network, and what inspired her to launch her own company in the neuroscience space.
A thoughtful conversation about leadership, risk-taking, and creating opportunities instead of waiting for them.
Chapters
00:00 Introduction
02:30 Discovering Science & Neuroscience
05:00 Moving from Academia to Industry
08:00 What Industry Looks for in Scientists
10:00 Seeing the Full Drug Development Picture
13:00 Why Great Science Isn't Enough
16:00 Funding Plans, Not Hope
19:00 From Executive to Founder
22:00 Building a Company in Neuroscience
25:00 Creating a Culture Where Every Voice Matters
28:00 Risk, Decision-Making & Leadership
31:00 The Future of Gene Therapy
34:00 Career Advice, Networking & Growth
#SheLeadsBiotech #WomenInBiotech #BiotechLeadership #GeneTherapy #Neuroscience #FemaleFounder #CNAUSAExecutiveSearch
Rethinking IVF with Ivana Muncie-Vasic
In this episode of She Leads Biotech, we’re joined by Ivana Muncie-Vasic, CEO & Founder of Vitra Labs, for a conversation about fertility innovation, bioengineering, and building a biotech company from the ground up.
Ivana shares how her work in stem cell biology led to the development of hormone-free IVF technology designed to reduce the physical and financial burden of fertility treatment for patients.
We also talk about the realities of becoming a first-time founder, navigating imposter syndrome, building resilience as a CEO, and how becoming a new mother has deepened her connection to the mission behind Vitra Labs.
Chapters
00:00 Introduction
02:00 Finding Bioengineering & Stem Cell Research
07:00 Why Patient Impact Became the Focus
10:00 From Academic Research to Founding Vitra Labs
14:00 The Science Behind Hormone-Free IVF
19:00 Why Traditional IVF Is So Difficult on Women
23:00 Becoming a First-Time CEO
27:00 Panic Attacks, Pressure & Founder Reality
31:00 The Importance of Support & Coaching
34:00 Becoming a Mother While Building a Startup
37:00 Advice for Future Founders
#SheLeadsBiotech #WomensHealth #FertilityInnovation #IVF #WomenInBiotech #CNAUSAExecutiveSearch
Changing the Conversation Around Women’s Health with Saundra Pelletier & Mitch Rosen
In this episode of She Leads Biotech, we’re joined by Saundra Pelletier and Mitch Rosen from Evofem Biosciences for a candid conversation about women’s health, education, intimacy, and the importance of normalizing these discussions.
We explore why women deserve more options, why men need to be part of the conversation too, and how a new generation is changing the way people think about sexual health and communication.
From access and advocacy to stigma, healthcare gaps, and the power of education, this episode is honest, insightful, and surprisingly fun.
Chapters
00:00 Introduction
03:00 Evofem, Phexxi & Women’s Choice
07:00 The “Say Vagina” Campaign
12:00 Why Men Need to Join the Conversation
16:00 How Mitch Found Women’s Health
21:00 What’s Changing in Women’s Healthcare
26:00 Shared Responsibility & Communication
31:00 Generational Shifts Around Intimacy
35:00 Myths & Misconceptions in Women’s Health
40:00 AI, Access & The Future of Care
45:00 What Real Progress Looks Like
49:00 Final Advice & Takeaways
#SheLeadsBiotech #WomensHealth #HealthcareInnovation #WomenInBiotech #CNAUSAExecutiveSearch
Trusting Your Judgement in Biotech with Anna Polak-Andersen
In this episode of She Leads Biotech, we’re joined by Anna Polak-Andersen, CEO of AnRes Clinical, for a thoughtful conversation about clinical development, leadership, and navigating the biotech industry across Europe.
Anna shares her journey from studying pharmacy in Poland to leading a clinical development consultancy supporting biotech companies and rare disease programs across the industry.
We talk about the realities of clinical research, the importance of strategic thinking in development, the current European biotech landscape, and why learning to trust your own judgement is one of the most important leadership lessons of all.
Chapters
00:00 Introduction
03:00 Why Anna Chose Clinical Development
08:00 Early Career at Pfizer
11:00 Staying Connected to Patient Impact
15:00 What Makes AnRes Clinical Different
20:00 Choosing the Right Clients & Partnerships
24:00 European Biotech & Funding Challenges
28:00 Women in Leadership & Self-Doubt
32:00 Trusting Your Own Judgement
35:00 Advice for the Next Generation
#SheLeadsBiotech #ClinicalDevelopment #WomenInBiotech #BiotechLeadership #CNAUSAExecutiveSearch
Building a biotech company takes more than science.
In this episode of She Leads Biotech, Dr. Stella Vnook, CEO of Aviva Ventures, shares her journey from arriving in the US with nothing to leading multiple biotech ventures and supporting the next generation of founders.
We explore the realities of building in biotech, from self-doubt and uncertainty to navigating the business side of science, and why so many great ideas never get started.
A practical and honest conversation about resilience, leadership, and what it really takes to turn science into impact.
Chapters
00:00 Introduction
01:30 Stella’s Early Journey
05:00 Building a Career in Life Sciences
09:00 Self-Doubt and Leadership
13:00 From Pharma to Entrepreneurship
18:00 Starting Without Knowing How
23:00 Common Mistakes Founders Make
27:00 Building Multiple Companies
32:00 The Story Behind Caerra
36:00 Aviva Ventures and Supporting Founders
40:00 Advice for Early-Stage Founders
44:00 What Success Looks Like
#SheLeadsBiotech #WomenInBiotech #BiotechLeadership #LifeSciences #CNAUSAExecutiveSearch
From the publisher's feed